AldermanCP, MoritzCK, Ben-TovimDI. Abnormal platelet aggregation associated with fluoxetine therapy. Ann Pharmacother. 1992;26: 1517–1519.
2.
AnouchiYS, ParkerRD, SeitzWHJr.Posterior compartment syndrome of the calf resulting from misdiagnosis of a rupture of the medial head of the gastrocnemius. J Trauma. 1987;27:678–680.
3.
AranthJ, LindbergC.Bleeding, a side effect of fluoxetine. Am J Psychiatry. 1992;149:412–412.
4.
BeallS, GarnerJ, OxleyD.Anterolateral compartment syndrome related to drug-induced bleeding: a case report. Am J Sports Med. 1983;11:454–455.
5.
BerkM, JacobsonBF, HurlyE.Fluoxetine and hemostatic function: a pilot study. J Clin Psychiatry. 1995;56:14–16.
6.
BraunwaldE, IsselbackerKJ, PetersdorfRG, WilsonJD, MartinJB, FauciAS, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 1987.
ChanCC, BoyceS, BrideauC, et al. Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther. 1999;290:551–560.
9.
ClaireRJ, ServisME, CramDLJr.Potential interaction between warfarin sodium and fluoxetine. Am J Psychiatry. 1991;148:1604–1604.
10.
DandonaP, JeremyJY. Nonsteroidal anti-inflammatory drug therapy and gastric side effects: does nabumetone provide a solution?Drugs. 1990;40(suppl 5):16–24.
11.
DentLA, OrrockMW. Warfarin-fluoxetine and diazepam-fluoxetine interaction. Pharmacotherapy. 1997;17:170–172.
FordyceMJ, LingRS. A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg Br. 1992;74:45–49.
14.
GeisGS. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?Scand J Rheumatol. 1999;109(suppl):31–37.
15.
GloviczkiP, FowlRJ, HollierLH, DewanjeeMK, PlateG, KayeMP. Prevention of platelet deposition by ibuprofen and calcium dobesilate in expanded polytetrafluoroethylene vascular grafts. Am J Surg. 1985;150:589–592.
HarderS, KlinkhardtU, AlvarezJM. Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet. 2004;43:963–981.
HumphriesJE, WhebyMS, VandenBergSR. Fluoxetine and the bleeding time. Arch Pathol Lab Med. 1990;114:727–728.
22.
JeremyJY, MikhailidisDP, BarradasMA, KirkRM, DandonaP.The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function. Br J Rheumatol. 1990;29:116–119.
23.
KromeJ, de AraujoW, WebbLX. Acute compartment syndrome in ruptured Baker's cyst. J South Orthop Assoc. 1997;6:110–114.
24.
Laine-CessacP, ShoaayI, GarreJB, GlaudV, TurcantA, AllainP.Study of haemostasis in depressive patients treated with fluoxetine. Pharmacoepidemiol Drug Saf. 1998;7(suppl 1):S54–S57.
25.
LanzaFL. Gastrointestinal toxicity of newer NSAIDs. Am J Gastroenterol. 1993;88:1318–1323.
26.
LazarusML, RayCEJr, ManiquisCG. MRI findings of concurrent acute DVT and dissecting popliteal cyst. Magn Reson Imaging. 1994; 12:155–158.
27.
LefkowithJB. Cyclooxygenase-2 specificity and its clinical implications. Am J Med. 1999;106:43S–50S.
28.
MadiganRR. Acute compartment syndrome in hemophilia: a case report. J Bone Joint Surg Am. 1982;64:313–313.
29.
NiYG, MilediR.Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci U S A. 1997;94:2036–2040.
30.
PaiVB, KellyMW. Bruising associated with the use of fluoxetine. Ann Pharmacother. 1996;30:786–788.
31.
PetrosDP, HanleyJF, GilbreathP, ToonRD. Posterior compartment syndrome following ruptured Baker's cyst. Ann Rheum Dis. 1990;49: 944–945.
32.
Physicians Desk Reference. Stamford, Conn: Thompson Healthcare; 2004.
33.
PolissonR.Nonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selection. Am J Med. 1996;100:31S–36S.
34.
RaoGH. Influence of anti-platelet drugs on platelet-vessel wall interactions. Prostaglandins Leukot Med. 1987;30:133–145.
35.
RaoGH, RaoAT. Pharmacology of platelet activation-inhibitory drugs. Indian J Physiol Pharmacol. 1994;38:69–84.
36.
SchattenkirchnerM.The safety profile of sustained-release etodolac. Rheumatol Int. 1993;13(2 suppl):S31–S35.
37.
VandelP, VandelS, KantelipJP. SSRI-induced bleeding: two case reports. Therapie. 2001;56:445–447.
38.
WalchliB, MolnarJ, InderbitziR.Rupture of a Baker cyst with compartment syndrome: a rare complication of knee arthroscopy [in German]. Chirurg. 1998;69:306–309.
39.
WerbelGB, ShybutGT. Acute compartment syndrome caused by a malfunctioning pneumatic-compression boot: a case report. J Bone Joint Surg Am. 1986;68:1445–1446.
40.
WestrichGH, SpechtLM, SharrockNE, et al. Pneumatic compression hemodynamics in total hip arthroplasty. Clin Orthop Relat Res. 2000; 372:180–191.
41.
WigleyRA, PatersonDE. Calf haematoma following anticoagulants in synovial rupture. N Z Med J. 1982;95:630–632.
42.
Yaryura-TobiasJA, KirschenH, NinanP, MosbergHJ. Fluoxetine and bleeding in obsessive-compulsive disorder. Am J Psychiatry. 1991; 148:949–949.
